The metabolism of solitary and repeated once-day-to-day doses of CONCERTA® is similar. Right after oral dosing of radiolabeled methylphenidate in people, about ninety% of the radioactivity was recovered in urine. The primary urinary metabolite was PPAA, accounting for approximately eighty% on the dose.In human beings, methylphenidate is metabolize